Chief Operating Officer

• Jun 2018 - Present

Head of Regulatory, Technical and Administration Systems

• Jan 2018 - Jun 2018

ARCINOVA is a privately owned, fast growing, internationally focussed SME, based in Alnwick, Northumberland. My role, as a key member of the Senior Executive Team of the business, is to be a Qualified Person and be responsible for the Regulatory, IT and HR functions.

Business Unit Director (Dermatology)

• Feb 2017 - Dec 2017

Leading the Dermatological Business Unit ensuring that customer demand, growth opportunities and New Product Introduction requirements are met. Accountable for the leadership of Production, Engineering, Planning and New Product Introduction associated with the Dermatological Business Unit (circa 150 people) with an annual budget of approx. £22m in recoveries and £15m Opex. Ensuring operational compliance with the applicable cGMP, QMS and EHS standards throughout the Business Unit via appropriate governance processes. Show less

Change Management Consultant

• Jan 2016 - Apr 2016

As the change management consultant working as an associate for Shott Trinova LLP, focussed on supporting/facilitating effective consultation processes and the compliant/timely regulatory transitions, which contributed to their successful acquisition of the ex. Covance research facility based at Alnwick. Post acquisition, leading the Business Integration Project to ensure that all key strategies, systems and processes are fully established. As the change management consultant working as an associate for Shott Trinova LLP, focussed on supporting/facilitating effective consultation processes and the compliant/timely regulatory transitions, which contributed to their successful acquisition of the ex. Covance research facility based at Alnwick. Post acquisition, leading the Business Integration Project to ensure that all key strategies, systems and processes are fully established.

Director of Operations

• Jul 2008 - Feb 2016

Overall responsibility and accountability for the operational performance of the production site employing around 450 employees covering a broad range of functions including Production, Quality, Health, Safety & Environment, Supply Chain, Finance, Human Resources, Procurement and Performance & Technical Support. Annual costs of production ranged from 80 to 95 £million and capital expenditure spanned 12 to 3 £million. Key Achievements: • Strong sponsorship and direction for major site improvements including Utilities (39% less used), Direct Labour Productivity (41% improvement), Product Cost (14% reduction despite inflationary increases), Inventory (£1.4 million saved on one Continuous Improvement Masterclass), Cost of Equipment, Maintenance & Repairs (50% reduction in spend), OEE (31% improvement), Product Throughput (29% reduction in days) • Sponsored and supported the development of internal employees resulting in the create and encourage the behaviours that engender ‘people engagement’ in Safety, Quality and Operational performance • Established a ‘Safety is the No. 1 Priority’ culture site wide • Successfully re-organised the Site Leadership team to plan and execute all necessary activities required to ensure full and timely product transfers and deployment of people support programmes for site closure Show less

Head of Production

• 2004 - 2008

Responsibility for the manufacture and packaging of solid dose forms, including effervescent tablets at circa 4 billion units (2500 tons & 73 formulas) and circa 80 million packs (600 SKUs) annually. Overall accountability for approximately 276 employees (238 directs, 38 in-directs) with a revenue budget of circa £650K (excluding compensation & depreciation) and annual capital expenditure ranging from £2 million to £5 million.Key Achievements:Unification of the production departments to ensure the application of consistent approaches, methodologies and standards.Leading and supporting a management team to consistently meet the key business objectives (MPS, Productivity, COGS, OEE, Cost Control). Show less

Head of Quality Assurance

• 2000 - 2004

Key Achievements:Reorganisation and rebuilding of the Quality Assurance and Quality Control functionsImplementation of a comprehensive Quality SystemEstablishment of a good working relationship with the MCA/MHRA regulatory authorities